資料集
搜尋結果
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
資料集: Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
資料集: Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
資料集: Dataset
-
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Chou, P.-C. (Contributor), Wen, K.-C. (Creator), Lee, M.-H. (Contributor), Lin, J.-H. (Contributor), Sung, P.-L. (Contributor), Yeung, S.-C. J. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://doi.org/10.6084%2Fm9.figshare.12845525.v1
資料集: Dataset
-
Triage of high-risk human papillomavirus-positive women by methylated POU4F3
Chen, Y.-C. (Contributor), Chang, C.-C. (Contributor), Wang, H.-C. (Creator), Lai, H.-C. (Contributor), Liao, Y.-P. (Creator), Huang, R.-L. (Creator), Pun, P. B. (Contributor), Su, P.-H. (Contributor) & Hsu, Y.-W. (Contributor), Figshare, 2015
DOI: 10.6084/m9.figshare.c.3630035.v1, https://doi.org/10.6084%2Fm9.figshare.c.3630035.v1
資料集: Dataset
-
MOESM1 of Ovarian cancer detection by DNA methylation in cervical scrapings
Wu, T.-I. (Contributor), Mao, S.-P. (Contributor), Lai, H.-C. (Contributor), Su, P.-H. (Contributor), Wu, C.-H. (Contributor) & Huang, R.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.11292929.v1, https://doi.org/10.6084%2Fm9.figshare.11292929.v1
資料集: Dataset
-
MOESM1 of Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings
Wang, H.-C. (Creator), Weng, Y.-C. (Creator), Wu, T.-I. (Contributor), Liew, P.-L. (Contributor), Lai, H.-C. (Contributor), Su, P.-H. (Contributor), Chen, C.-W. (Contributor), Liao, C.-C. (Contributor) & Huang, R.-L. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.11296943.v1, https://doi.org/10.6084%2Fm9.figshare.11296943.v1
資料集: Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Wu, A. T. H. (Creator), Yeung, S.-C. J. (Contributor), Wen, K.-C. (Creator), Chou, P.-C. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor) & Sung, P.-L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
資料集: Dataset
-
Additional file 1: Table S1. of Triage of high-risk human papillomavirus-positive women by methylated POU4F3
Chen, Y.-C. (Contributor), Liao, Y.-P. (Creator), Wang, H.-C. (Creator), Lai, H.-C. (Contributor), Su, P.-H. (Contributor), Hsu, Y.-W. (Contributor), Pun, P. B. (Contributor), Chang, C.-C. (Contributor) & Huang, R.-L. (Creator), Figshare, 2015
DOI: 10.6084/m9.figshare.c.3630035_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3630035_d1.v1
資料集: Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
資料集: Dataset
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
資料集: Dataset